Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Oct 1;22(10):1686-91.
doi: 10.1161/01.atv.0000033090.81345.e6.

Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia

Jeffrey B Boord  1 , Kazuhisa Maeda, Liza Makowski, Vladimir R Babaev, Sergio Fazio, MacRae F Linton, Gökhan S Hotamisligil
Affiliations

Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia

Jeffrey B Boord et al. Arterioscler Thromb Vasc Biol. .

Abstract

Objective: The adipocyte fatty acid-binding protein, aP2, has important effects on insulin resistance, lipid metabolism, and atherosclerosis. Its expression in macrophages enhances early foam cell formation and atherosclerosis in vivo. This study was designed to determine whether aP2 deficiency has a similar effect in the setting of advanced atherosclerosis and severe hypercholesterolemia.

Methods and results: Mice deficient in aP2 and apolipoprotein E (aP2(-/-)apoE(-/-) mice) and apolipoprotein E-deficient control mice (apoE(-/-) mice) were fed a Western diet for 14 weeks. No significant differences in fasting serum levels of cholesterol, triglycerides, or free fatty acids were found between groups for each sex. Compared with apoE(-/-) control mice, male and female aP2(-/-)apoE(-/-) mice had significant reductions in mean atherosclerotic lesion size in the proximal aorta, en face aorta, and innominate/right carotid artery. Feeding the Western diet in the apoE-deficient background did not cause a significant reduction in insulin sensitivity in vivo, as determined by steady-state serum glucose levels and insulin tolerance testing.

Conclusions: These data demonstrate an important role for aP2 expression in the advanced stages of atherosclerotic lesion formation. Thus, aP2 provides an important physiological link between different features of the metabolic syndrome and is a potential _target for therapy of atherosclerosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Lipoprotein distribution in male and female aP2−/−apoE−/− and aP2+/+apoE−/− mice. Data are an average (n=4 for each group) percent distribution of total cholesterol for each group. Fractions 14 to 17 contain VLDL; fractions 18 to 24, IDL/LDL; and fractions 25 to 29, HDL. Fractions 30 to 40 are non-lipoprotein-associated proteins.
Figure 2
Figure 2
Insulin tolerance tests in male (A) and female (B) aP2−/−apoE−/− and aP2+/+apoE−/− mice. Insulin tolerance tests were performed with 0.5 U/kg human insulin injected intraperitoneally per animal. Data are mean±SEM. P=NS between groups for all time points in both panels.
Figure 3
Figure 3
Quantification of atherosclerotic lesion area in the proximal aorta (A), en face aorta (B), and innominate/right carotid artery (C) in male and female aP2−/−apoE−/− and aP2+/+apoE−/− mice. Data are average mean lesion area for each group, with error bars indicating SEM. Probability values are as indicated. Student t test was used for data in panels A and B, and the Mann-Whitney test was used for data in panel C.
Figure 4
Figure 4
Immunocytochemical detection of macrophages in the proximal aorta of male and female aP2−/−apoE−/− and aP2+/+apoE−/− mice. Macrophages are stained with antibody to mouse macrophage clone, MOMA-2.
Figure 5
Figure 5
Histological appearance of atherosclerotic lesions in the proximal aorta. Each micrograph is a representative section from each group. Frozen 5-μm sections were fixed and stained with Masson's trichrome and captured with an Olympus PRO-VIS AX70 microscope and digital camera at ×200 magnification.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

  • Adipose inflammation at the heart of vascular disease.
    Autieri MV. Autieri MV. Clin Sci (Lond). 2016 Nov 1;130(22):2101-2104. doi: 10.1042/CS20160628. Clin Sci (Lond). 2016. PMID: 27729474 Free PMC article.
  • Regulation of macrophage functions by FABP-mediated inflammatory and metabolic pathways.
    Jin R, Hao J, Yi Y, Sauter E, Li B. Jin R, et al. Biochim Biophys Acta Mol Cell Biol Lipids. 2021 Aug;1866(8):158964. doi: 10.1016/j.bbalip.2021.158964. Epub 2021 May 10. Biochim Biophys Acta Mol Cell Biol Lipids. 2021. PMID: 33984518 Free PMC article. Review.
  • Receptor mediated elevation in FABP4 levels by advanced glycation end products induces cholesterol and triacylglycerol accumulation in THP-1 macrophages.
    Wang XQ, Yang K, He YS, Lu L, Shen WF. Wang XQ, et al. Lipids. 2011 Jun;46(6):479-86. doi: 10.1007/s11745-011-3542-4. Epub 2011 Feb 20. Lipids. 2011. PMID: 21336983
  • Carnitine transport and fatty acid oxidation.
    Longo N, Frigeni M, Pasquali M. Longo N, et al. Biochim Biophys Acta. 2016 Oct;1863(10):2422-35. doi: 10.1016/j.bbamcr.2016.01.023. Epub 2016 Jan 29. Biochim Biophys Acta. 2016. PMID: 26828774 Free PMC article. Review.
  • Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease.
    Zhao W, Rasheed A, Tikkanen E, Lee JJ, Butterworth AS, Howson JMM, Assimes TL, Chowdhury R, Orho-Melander M, Damrauer S, Small A, Asma S, Imamura M, Yamauch T, Chambers JC, Chen P, Sapkota BR, Shah N, Jabeen S, Surendran P, Lu Y, Zhang W, Imran A, Abbas S, Majeed F, Trindade K, Qamar N, Mallick NH, Yaqoob Z, Saghir T, Rizvi SNH, Memon A, Rasheed SZ, Memon FU, Mehmood K, Ahmed N, Qureshi IH, Tanveer-Us-Salam, Iqbal W, Malik U, Mehra N, Kuo JZ, Sheu WH, Guo X, Hsiung CA, Juang JJ, Taylor KD, Hung YJ, Lee WJ, Quertermous T, Lee IT, Hsu CC, Bottinger EP, Ralhan S, Teo YY, Wang TD, Alam DS, Di Angelantonio E, Epstein S, Nielsen SF, Nordestgaard BG, Tybjaerg-Hansen A, Young R; CHD Exome+ Consortium; Benn M, Frikke-Schmidt R, Kamstrup PR; EPIC-CVD Consortium; EPIC-Interact Consortium; Michigan Biobank; Jukema JW, Sattar N, Smit R, Chung RH, Liang KW, Anand S, Sanghera DK, Ripatti S, Loos RJF, Kooner JS, Tai ES, Rotter JI, Chen YI, Frossard P, Maeda S, Kadowaki T, Reilly M, Pare G, Melander O, Salomaa V, Rader DJ, Danesh J, Voight BF, Saleheen D. Zhao W, et al. Nat Genet. 2017 Oct;49(10):1450-1457. doi: 10.1038/ng.3943. Epub 2017 Sep 4. Nat Genet. 2017. PMID: 28869590 Free PMC article.
See all "Cited by" articles

References

    1. Storch J, Thumser AE. The fatty acid transport function of fatty acid-binding proteins. Biochim Biophys Acta. 2000;1486:28–44. - PubMed
    1. Coe NR, Bernlohr DA. Physiological properties and functions of intracellular fatty acid-binding proteins. Biochim Biophys Acta. 1998;1391:287–306. - PubMed
    1. Distel RJ, Robinson GS, Spiegelman BM. Fatty acid regulation of gene expression: transcriptional and post-transcriptional mechanisms. J Biol Chem. 1992;267:5937–5941. - PubMed
    1. Chaput E, Saladin R, Silvestre M, Edgar AD. Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight. Biochem Biophys Res Commun. 2000;271:445–450. - PubMed
    1. Melki SA, Abumrad NA. Expression of the adipocyte fatty acid-binding protein in streptozotocin-diabetes: effects of insulin deficiency and supplementation. J Lipid Res. 1993;34:1527–1534. - PubMed

Publication types

  NODES
twitter 2